At TCG Lifesciences (TCGLS), our Safety and Toxicology platform supports IND-enabling safety evaluation by providing comprehensive assessment of compound, bridging the gap between discovery and clinical development that requires in-depth characterization of the test compound for its safety profile. Safety and toxicology platform of TCGLS is comprehensive to deliver a wide range of safety assessment results required for fulfilment of a complete IND-enabling study package.
End-to-end safety evaluation from early risk assessment to exploratory and regulatory toxicology.
Integrated capabilities across in silico, in vitro, and in vivo safety and safety pharmacology studies.
Platforms designed to support IND-enabling safety packages for progression toward clinical development.
Studies conducted in regulated facilities with CCSEA registration, AAALAC International accreditation, and GLP-certified platforms to meet global regulatory requirements.
Our Core Capabilities
